Ningbo Benkangjishi Pharmaceutical Technology Co., Ltd. is mainly engaged in the 

research  and development of biotechnology and pharmaceutical technology, technical 

consultation, technical services, technology transfer; sales of pharmaceutical intermediates 

and chemical products; import and export of self-operated or agent goods and technologies.

        The company has built a multi-category, novel structure and high performance drug 

molecular  block library for global pharmaceutical enterprises. By using and combining these 

molecular blocks, new drug R&D enterprises can quickly obtain a large number of candidate

 compounds for screening and evaluation in drug discovery phase, and efficiently discover the

 structure-activity relationship of compounds, and ultimately determine clinical candidates.

        In order to satisfy customers'different demands for chemical synthesis at all stages of 

new drug research and development and provide more comprehensive and long-term stable 

high-quality services, the company continues to provide laboratory-level molecular blocks,

 while developing and strengthening the commercial production capacity of drug molecular 

blocks and key intermediates. It can produce kilogram to ton grade molecular blocks,

 GMP and non-GMP intermediates.

        The company has been in line with the concept of "customer first, sharing and win-win", 

to provide global pharmaceutical and biotechnology companies with innovative new drug

 development, difficult to synthesize products and services. At present, the company's core 

 business is focused on:     

●Molecular block

●Technological research and development

●Small Molecular Library Compounds

●Commercial reagents and raw materials

         The company is committed to helping customers save the cost of new drug development

 and shorten the time of new drug marketing, and contribute to the fight against disease.